FDA promotes OTC safety
This article was originally published in The Tan Sheet
United Health Foundation is teaming with FDA on a national health education campaign designed to promote safe use of OTCs. Targeted to women ages 25-60, print ads include a Q&A reminding OTC users to read and follow directions, avoid taking products with the same active ingredient and consult healthcare professionals in the event of side effects. The ads will appear in magazines such as People, Good Housekeeping and Ebony, as well as online news sources Yahoo!, AOL and ABCNews.com. The campaign echoes an OTC safety initiative launched by the agency last year (1"The Tan Sheet" Jan. 26, 2004, p. 8)...
You may also be interested in...
FDA launched a public educational campaign Jan. 22 warning consumers about the link between acetaminophen and liver damage, and potential renal and gastrointestinal problems associated with nonsteroidal anti-inflammatory use
Formycon’s CEO has offered the latest indication that the coronavirus outbreak could provide a tailwind for biosimilars, as the firm gave an update on its biosimilars pipeline – including ranibizumab, ustekinumab, aflibercept and an undisclosed molecule, as well as other unrevealed projects – and how it has been affected by the pandemic.
With the formal, virtual kick-off meeting set for 23 July, US FDA and sponsors are looking at a transformed landscape as they discuss what the next five years of user fees will look like.